Please login to the form below

Not currently logged in
Email:
Password:

raltegravir

This page shows the latest raltegravir news and features for those working in and with pharma, biotech and healthcare.

MSD claims EU approval for two HIV products

MSD claims EU approval for two HIV products

which is currently led by blockbuster integrase inhibitor Isentress (raltegravir).

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....